IP
CRDF icon

Intellectus Partners’s Cardiff Oncology CRDF Stock Holding History

Intellectus Partners’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-28
Closed – – 301
2018
Q3 		$0 Buy
+28
New +$133 ﹤0.01% 579
2018
Q2 		– Sell
-28
Closed -$1K – 590
2018
Q1 		$1K Hold
28
– – ﹤0.01% 579
2017
Q4 		$1K Hold
28
– – ﹤0.01% 593
2017
Q3 		$1K Hold
28
– – ﹤0.01% 751
2017
Q2 		$3K Hold
28
– – ﹤0.01% 701
2017
Q1 		$2K Hold
28
– – ﹤0.01% 656
2016
Q4 		$4K Buy
+28
New +$6.54K ﹤0.01% 615

Other funds holding CRDF

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Intellectus Partners's CRDF Position: Q4 2018 in Review

Intellectus Partners sold out of Cardiff Oncology (CRDF) in Q4 2018, closing a stake of 28 shares.

Intellectus Partners first reported a position in CRDF in Q4 2016 and held it in 7 quarters. The position peaked at $4K in Q4 2016. 26 funds tracked by Wall St. Rank hold CRDF as of Q4 2018.

  • Intellectus Partners reported no remaining Cardiff Oncology position as of Q4 2018 after selling out during the quarter.
  • Intellectus Partners sold 28 Cardiff Oncology shares in Q4 2018.
  • Intellectus Partners first reported a position in Cardiff Oncology in Q4 2016 and held it in 7 quarters.
  • Intellectus Partners's Cardiff Oncology position peaked at $4K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.